Bevacizumab in Combination With Sintilimab Versus Transcatheter Arterial Chemoembolization for the Treatment of Intermediate Stage Hepatocellular Carcinoma (Beyond Up-To-Seven Criteria)
Clinical trial NCT06090656 · UNKNOWN
Trial details
- NCT number
- NCT06090656
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-02
- Primary completion
- 2025-07-25
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.